In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

Saved in:
Bibliographic Details
Title: In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.
Authors: Lee CYC; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Dean I; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Richoz N; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom., Li Z; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Kennedy BC; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Vettore LA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Samarakoon Y; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom., Gilroy KL; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Hasegawa T; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom., Carlesso G; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Hammond SA; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Dovedi SJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Sansom OJ; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Tuong ZK; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Halim TYF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom., Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom., Clatworthy MR; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
Source: Cancer immunology research [Cancer Immunol Res] 2025 Sep 02; Vol. 13 (9), pp. 1453-1470.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40523200
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+CYC%22">Lee CYC</searchLink>; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dean+I%22">Dean I</searchLink>; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Richoz+N%22">Richoz N</searchLink>; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kennedy+BC%22">Kennedy BC</searchLink>; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vettore+LA%22">Vettore LA</searchLink>; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Samarakoon+Y%22">Samarakoon Y</searchLink>; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gilroy+KL%22">Gilroy KL</searchLink>; Cancer Research UK Scotland Institute, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hasegawa+T%22">Hasegawa T</searchLink>; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carlesso+G%22">Carlesso G</searchLink>; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Hammond+SA%22">Hammond SA</searchLink>; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Dovedi+SJ%22">Dovedi SJ</searchLink>; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sansom+OJ%22">Sansom OJ</searchLink>; Cancer Research UK Scotland Institute, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tuong+ZK%22">Tuong ZK</searchLink>; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Halim+TYF%22">Halim TYF</searchLink>; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Withers+DR%22">Withers DR</searchLink>; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; NDM Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Clatworthy+MR%22">Clatworthy MR</searchLink>; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2025 Sep 02; Vol. 13 (9), pp. 1453-1470.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40523200
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-24-1233
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1453
    Titles:
      – TitleFull: In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee CYC
      – PersonEntity:
          Name:
            NameFull: Dean I
      – PersonEntity:
          Name:
            NameFull: Richoz N
      – PersonEntity:
          Name:
            NameFull: Li Z
      – PersonEntity:
          Name:
            NameFull: Kennedy BC
      – PersonEntity:
          Name:
            NameFull: Vettore LA
      – PersonEntity:
          Name:
            NameFull: Samarakoon Y
      – PersonEntity:
          Name:
            NameFull: Gilroy KL
      – PersonEntity:
          Name:
            NameFull: Hasegawa T
      – PersonEntity:
          Name:
            NameFull: Carlesso G
      – PersonEntity:
          Name:
            NameFull: Hammond SA
      – PersonEntity:
          Name:
            NameFull: Dovedi SJ
      – PersonEntity:
          Name:
            NameFull: Sansom OJ
      – PersonEntity:
          Name:
            NameFull: Tuong ZK
      – PersonEntity:
          Name:
            NameFull: Halim TYF
      – PersonEntity:
          Name:
            NameFull: Withers DR
      – PersonEntity:
          Name:
            NameFull: Clatworthy MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Sep 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1